These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29440719)

  • 1. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
    Modinos G; Şimşek F; Azis M; Bossong M; Bonoldi I; Samson C; Quinn B; Perez J; Broome MR; Zelaya F; Lythgoe DJ; Howes OD; Stone JM; Grace AA; Allen P; McGuire P
    Neuropsychopharmacology; 2018 Dec; 43(13):2652-2659. PubMed ID: 29440719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.
    Allen P; Azis M; Modinos G; Bossong MG; Bonoldi I; Samson C; Quinn B; Kempton MJ; Howes OD; Stone JM; Calem M; Perez J; Bhattacharayya S; Broome MR; Grace AA; Zelaya F; McGuire P
    Schizophr Bull; 2018 Oct; 44(6):1323-1331. PubMed ID: 29294102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms.
    Modinos G; Simsek F; Horder J; Bossong M; Bonoldi I; Azis M; Perez J; Broome M; Lythgoe DJ; Stone JM; Howes OD; Murphy DG; Grace AA; Allen P; McGuire P
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):114-119. PubMed ID: 29020419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
    Da Silva T; Hafizi S; Rusjan PM; Houle S; Wilson AA; Prce I; Sailasuta N; Mizrahi R
    J Psychiatry Neurosci; 2019 Mar; 44(2):111-119. PubMed ID: 30255837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
    Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trajectory of Prefrontal GABA Levels in Initially Antipsychotic-Naïve Patients With Psychosis During 2 Years of Treatment and Associations With Striatal Cerebral Blood Flow and Outcome.
    Bojesen KB; Rostrup E; Sigvard AK; Mikkelsen M; Edden RAE; Ebdrup BH; Glenthøj B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jul; 9(7):703-713. PubMed ID: 38145706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis.
    Allen P; Chaddock CA; Egerton A; Howes OD; Bonoldi I; Zelaya F; Bhattacharyya S; Murray R; McGuire P
    Am J Psychiatry; 2016 Apr; 173(4):392-9. PubMed ID: 26684922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.
    Allen P; Luigjes J; Howes OD; Egerton A; Hirao K; Valli I; Kambeitz J; Fusar-Poli P; Broome M; McGuire P
    Schizophr Bull; 2012 Nov; 38(6):1268-76. PubMed ID: 22290265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.
    Livingston NR; Kiemes A; Devenyi GA; Knight S; Lukow PB; Jelen LA; Reilly T; Dima A; Nettis MA; Casetta C; Agyekum T; Zelaya F; Spencer T; De Micheli A; Fusar-Poli P; Grace AA; Williams SCR; McGuire P; Egerton A; Chakravarty MM; Modinos G
    Neuropsychopharmacology; 2024 Aug; 49(9):1448-1458. PubMed ID: 38658738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced
    Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
    Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study.
    Wood SJ; Kennedy D; Phillips LJ; Seal ML; Yücel M; Nelson B; Yung AR; Jackson G; McGorry PD; Velakoulis D; Pantelis C
    Neuroimage; 2010 Aug; 52(1):62-8. PubMed ID: 20399273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months.
    Wenneberg C; Glenthøj BY; Glenthøj LB; Fagerlund B; Krakauer K; Kristensen TD; Hjorthøj C; Edden RAE; Broberg BV; Bojesen KB; Rostrup E; Nordentoft M
    Eur Psychiatry; 2020 Aug; 63(1):e83. PubMed ID: 32762779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.
    Bossong MG; Antoniades M; Azis M; Samson C; Quinn B; Bonoldi I; Modinos G; Perez J; Howes OD; Stone JM; Allen P; McGuire P
    JAMA Psychiatry; 2019 Feb; 76(2):199-207. PubMed ID: 30427993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
    Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical and brain functional changes in the ventromedial prefrontal cortex of first-episode psychosis patients: A combined functional magnetic resonance imaging-proton magnetic resonance spectroscopy study.
    Cen H; Xu J; Yang Z; Mei L; Chen T; Zhuo K; Xiang Q; Song Z; Wang Y; Guo X; Wang J; Jiang K; Xu Y; Li Y; Liu D
    Aust N Z J Psychiatry; 2020 May; 54(5):519-527. PubMed ID: 31958975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPO expression and brain structure in the psychosis spectrum.
    Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
    Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.